Trifenagrel

• CAT Number: I037498
• CAS Number: 84203-09-8
• Molecular Formula: C25H25N3O
• Molecular Weight: 383.49
• Purity: ≥95%
• Synonyms: 2-[2-(4,5-diphenyl-1H-imidazol-2-yl)phenoxy]-N,N-dimethylethanamine
• InChI: InChI=1S/C25H25N3O/c1-28(2)17-18-29-22-16-10-9-15-21(22)25-26-23(19-11-5-3-6-12-19)24(27-25)20-13-7-4-8-14-20/h3-16H,17-18H2,1-2H3,(H,26,27)
• InChIKey: KGVYOGLFOPNPDJ-UHFFFAOYSA-N
• SMILES: CN(C)CCOC1=CC=CC=C1C2=NC(=C(N2)C3=CC=CC=C3)C4=CC=CC=C4

Trifenagrel (Cat No.: I037498) is a selective antiplatelet agent that works by inhibiting the activation of platelet aggregation, which plays a key role in thrombosis and cardiovascular diseases. It is primarily studied for its potential in preventing and treating conditions such as stroke, myocardial infarction, and other thromboembolic disorders. Trifenagrel targets specific receptors or enzymes involved in platelet activation and thrombus formation, offering a targeted approach to manage blood clotting disorders. Clinical studies are ongoing to assess its efficacy, safety, and long-term benefits in cardiovascular health.

Reference

[1]. Abrahams SL, et al. Trifenagrel: a chemically novel platelet aggregation inhibitor. J Pharmacol Exp Ther. 1989 May;249(2):359-65.
[Content Brief]